Novo Integrated Sciences Cash Flow from Investing Activities 2012-2024 | NVOS
Novo Integrated Sciences cash flow from investing activities from 2012 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
Novo Integrated Sciences Annual Cash Flow Investing
(Millions of US $) |
| 2024 |
$0 |
| 2023 |
$0 |
| 2022 |
$0 |
| 2021 |
$3 |
| 2020 |
$1 |
| 2019 |
$-1 |
| 2018 |
$0 |
| 2017 |
$-1 |
| 2016 |
$0 |
| 2016 |
$0 |
| 2015 |
$0 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2011 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-OUTP/HM CRE |
$0.000B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
